Connection
Matthew McLaughlin to Cerebral Palsy
This is a "connection" page, showing publications Matthew McLaughlin has written about Cerebral Palsy.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
4.031 |
|
|
|
-
McLaughlin M, Inanoglu D. Decreased clinical response to therapy in pediatric patients with cerebral palsy: Current trends and challenges. J Pediatr Rehabil Med. 2021; 14(2):307-314.
Score: 0.899
-
McLaughlin MJ, Ratnasingam D, McGhee E. Variability of Steady State Oral Baclofen Prescribing Practices in Pediatric Patients With Cerebral Palsy. Am J Phys Med Rehabil. 2020 05; 99(5):441-443.
Score: 0.858
-
McLaughlin MJ, Fisher MT, Vadivelu S, Ramsey J, Ratnasingam D, McGhee E, Hartman K. A risk-stratified approach toward safely resuming OnabotulinumtoxinA injections based on dosing and ambulatory status in pediatric patients with cerebral palsy during the Coronavirus pandemic of 2019 (COVID-19). J Pediatr Rehabil Med. 2020; 13(3):273-279.
Score: 0.839
-
Weinstein SM, McLaughlin M. Ask the Authors. PM R. 2018 03; 10(3):243-244.
Score: 0.722
-
McLaughlin MJ, He Y, Brunstrom-Hernandez J, Thio LL, Carleton BC, Ross CJD, Gaedigk A, Lewandowski A, Dai H, Jusko WJ, Leeder JS. Pharmacogenomic Variability of Oral Baclofen Clearance and Clinical Response in Children With Cerebral Palsy. PM R. 2018 03; 10(3):235-243.
Score: 0.713